Abstract:Dominant optic atrophy (DOA) is one of the most prevalent forms of hereditary optic neuropathies and is mainly caused by heterozygous variants in OPA1 , encoding a mitochondrial dynamin-related large GTPase. The clinical spectrum of DOA has been extended to a wide variety of syndromic presentations, called DOA plus , including deafness as the main secondary symptom associated to vision impairment. To date, the pathophysiological mechanisms underlying the deafness in DOA remain unknown. To gain insights into the process leading to hearing impairment, we have analyzed the Opa1 delTTAG mouse model that recapitulates the DOA plus syndrome through complementary approaches combining morpho-physiology, biochemistry, and cellular and molecular biology. We found that Opa1 delTTAG mutation leads an adult-onset progressive auditory neuropathy in mice, as attested by the auditory brainstem response threshold shift over time. However, the mutant mice harbored larger otoacoustic emissions in comparison to wild-type littermates, whereas the endocochlear potential, which is a proxy for the functional state of the stria vascularis , was comparable between both genotypes. Ultrastructural examination of the mutant mice revealed a selective loss of sensory inner hair cells, together with a progressive degeneration of the axons and myelin sheaths of the afferent terminals of the spiral ganglion neurons, supporting an auditory neuropathy spectrum disorder (ANSD). Molecular assessment of cochlea demonstrated a reduction of Opa1 mRNA level by greater than 40%, supporting haploinsufficiency as the disease mechanism. In addition, we evidenced an early increase in Sirtuin 3 level and in Beclin1 activity, and subsequently an age-related mtDNA depletion, increased oxidative stress, mitophagy as well as an impaired autophagic flux. Together, these results support a novel role for OPA1 in the maintenance of inner hair cells and auditory neural structures, addressing new challenges for the exploration and treatment of OPA1-linked ANSD in patients.

OSBPL2 mutations impair autophagy and lead to hearing loss, potentially remedied by rapamycin

Mutations of Human NARS2, Encoding the Mitochondrial Asparaginyl-Trna Synthetase, Cause Nonsyndromic Deafness and Leigh Syndrome

Mutations in OSBPL2 cause hearing loss associated with primary cilia defects via sonic hedgehog signaling

Mutation of SLC7A14 causes auditory neuropathy and retinitis pigmentosa mediated by lysosomal dysfunction

Syndromic Deafness Gene ATP6V1B2 Controls Degeneration of Spiral Ganglion Neurons Through Modulating Proton Flux

OSBPL2-disrupted pigs recapitulate dual features of human hearing loss and hypercholesterolaemia

The human OPA1delTTAG mutation induces adult onset and progressive auditory neuropathy in mice

Mutation of the Atp-Gated P2x(2) Receptor Leads to Progressive Hearing Loss and Increased Susceptibility to Noise

OSBPL2 inhibition leads to apoptosis of cochlea hair cells in age-related hearing loss by inhibiting the AKT/FOXG1 signaling pathway

GPRASP2 deficiency contributes to apoptosis in the spiral ganglion cells via the AMPK/DRP1 signaling pathway

S1PR2 Variants Associated with Auditory Function in Humans and Endocochlear Potential Decline in Mouse

Restoring autophagic flux attenuates cochlear spiral ganglion neuron degeneration by promoting TFEB nuclear translocation via inhibiting MTOR.

Adenosine A2B Receptor: A Pathogenic Factor and a Therapeutic Target for Sensorineural Hearing Loss

Pathological mechanisms and candidate therapeutic approaches in the hearing loss of mice carrying human mutations

Excessive processing and acetylation of OPA1 aggravate age‐related hearing loss via the dysregulation of mitochondrial dynamics

Slc26a4-insufficiency Causes Fluctuating Hearing Loss and Stria Vascularis Dysfunction

Synaptojanin2 Mutation Causes Progressive High-frequency Hearing Loss in Mice

PAM-flexible Adenine Base Editing Rescues Hearing Loss in a Humanized MPZL2 Mouse Model Harboring an East Asian Founder Mutation

Auditory Pathology in a Transgenic mtTFB1 Mouse Model of Mitochondrial Deafness

Potential role of modulating autophagy levels in sensorineural hearing loss

In vivo outer hair cell gene editing ameliorates progressive hearing loss in dominant-negative Kcnq4 murine model